<![CDATA[Dr Patel on the BTCRC HN17-111 Trial of ADT Plus Pembrolizumab in Salivary Gland Cancer]]>
“Our thought was to use ADT as a way of enhancing immune therapy responses in [patients with salivary gland cancer].” Manish Patel, DO, a medical oncologist at the University of Minnesota Health and an associate professor of medicine in the Division of …